this site is intended for U.S. healthcare professionals only.

By clicking continue, you certify that you are a U.S. healthcare professional.

this site is intended for U.S. healthcare professionals only.

By clicking continue, you certify that you are a U.S. healthcare professional.

this site is intended for U.S. healthcare professionals only.

By clicking continue, you certify that you are a U.S. healthcare professional.

support that simplifies access 

a copay program, e‑vouchers, and more

Amerithroid is covered by many commercial plans, with copay assistance for eligible patients. We also offer a direct-to-patient, cash-pay option for families who prefer the convenience of having medicine delivered directly to their home.* 

supporting access and lower copays 

two ways to save

copay savings support with Relay Health eVoucherRx

Available at more than 50,000 pharmacies nationwide, including Walgreens and Walmart

Works with their insurance to help reduce their costs even further

No printing or forms required—everything is handled electronically

Copay discount is applied automatically when they show up to fill their prescription

If their pharmacy does not participate, they can visit the Relay Health website to find one that does

If their pharmacy does not participate, they can visit the Relay Health website to find one that does

pharmacy not in the Relay Health network?

No activation required

Patient can bring a physical card from your office to the pharmacy

Used with their insurance, it can help lower their costs

Applies a discount even if they pay cash

* Commercially insured patients will not have their prescription processed through their insurance. Subject to terms, conditions, and eligibility restrictions.

pharmacy not in the Relay Health network?

No activation required

Patient can bring a physical card from your office to the pharmacy

Used with their insurance, it can help lower their costs

Applies a discount even if they pay cash

* Commercially insured patients will not have their prescription processed through their insurance. Subject to terms, conditions, and eligibility restrictions.

pharmacy not in the Relay Health network?

No activation required

Patient can bring a physical card from your office to the pharmacy

Used with their insurance, it can help lower their costs

Applies a discount even if they pay cash

* Commercially insured patients will not have their prescription processed through their insurance. Subject to terms, conditions, and eligibility restrictions.

Oliva2You logo
Oliva2You logo
Home delivery

Home delivery

Home delivery

†

Medications shipped directly to your patient

Automatic refill

Automatic refills

Never miss a dose or run out

Transparent pricing

As little as $30** for a month's supply

No signature required

No signature required

Hassle-free delivery

prescribing amerithroid

To help ensure your patients receive amerithroid as prescribed, write “dispense as written” (DAW 1) on the prescription.§

Commercially insured patients will not have their prescription processed through their insurance.Patients enrolling in Oliva2You may not utilize insurance benefits, including any federal, state, or government-funded insurance program. In addition, patients enrolling in Oliva2You may not have payments applied to true out-of-pocket (TrOOP) costs.Subject to the terms, conditions, and eligibility restrictions outlined below.Dispense as written or equivalent language in your state. Pharmacy rules and local laws may vary.

“Thyroid treatment is rooted in quality, consistency, and giving patients trusted options to support their personal care. That is our mission and commitment.”

—Daniel Akeson, CEO

Oliva Therapeutics

a natural thyroid option from a trusted name

Backed by a team with extensive thyroid experience, amerithroid offers a high-quality option for patients considering a natural therapy for hypothyroidism that you can feel confident prescribing. 

Amerithroid logo
jerome stevens pharmaceuticals, inc. logo

a natural thyroid option from a trusted name

Backed by a team with extensive thyroid experience, amerithroid offers a high-quality option for patients considering a natural therapy for hypothyroidism that you can feel confident prescribing. 

Amerithroid logo
jerome stevens pharmaceuticals, inc. logo

a natural thyroid option from a trusted name

Backed by a team with extensive thyroid experience, amerithroid offers a high-quality option for patients considering a natural therapy for hypothyroidism that you can feel confident prescribing. 

Amerithroid logo
jerome stevens pharmaceuticals, inc. logo

TERMS, CONDITIONS, AND ELIGIBILITY CRITERIA

  1. This card is not valid for prescriptions submitted for reimbursement to Medicare, Medicaid, Medigap, VA, DOD, or TriCare, or where prohibited by law; to other federal or state programs (including any state pharmaceutical assistance programs); or to private indemnity or HMO insurance plans that reimburse you for the entire cost of your prescription drugs. Patients may not use this card if Amerithroid is covered under their Medicare prescription drug plan or if they are Medicare-eligible and enrolled in an employer-sponsored health plan or prescription drug benefit program for retirees.

  2. This card is good for use only with an Amerithroid prescription at the time the prescription is filled by the pharmacist and dispensed to the patient.

  3. This offer is good for 18 uses per patient, per calendar year, or until the program expires, whichever comes first.

  4. Maximum reimbursement limits apply; patient out-of-pocket expenses may vary.

  5. Oliva reserves the right to rescind, revoke, or amend this offer without notice.

  6. Offer good only in the US, except California and Massachusetts, at participating retail pharmacies.

  7. Void if prohibited by law, taxed, or restricted.

  8. The selling, purchasing, trading, or counterfeiting of this card is prohibited by law.

By downloading the savings card, I certify that I am not covered by:

  • Any federal or state healthcare program, such as Medicare, Medicaid, etc., including state medical or pharmaceutical assistance programs;

  • The Medicare Prescription Drug Program (Part D), or in the coverage gap; or

  • Insurance that is paying the entire cost of the prescription

I agree to this certification and have read and accepted the Program Terms, Conditions, and Eligibility Criteria.

I certify that I am 18 years of age or older and completing this for myself or a dependent.

Decorative reflection of woman in Utah
Woman in Utah
Decorative reflection of woman in Utah
Woman in Utah
Decorative reflection of woman in Utah
Woman in Utah
Decorative Utah corner image
Decorative Utah corner image
Decorative Utah corner image

Note that DTE products, including amerithroid, have not been reviewed by the FDA for safety or efficacy.

Indications and Usage 

Thyroid Tablets, USP are indicated for:

  • Replacement or supplemental therapy in hypothyroidism of any etiology (except transient hypothyroidism during recovery from subacute thyroiditis) 

  • TSH suppression in the management of certain goiters and in thyroid cancer 

contraindications

  • Uncorrected adrenal cortical insufficiency

  • Untreated thyrotoxicosis

  • Known hypersensitivity to thyroid hormone preparations or excipients 

IMPORTANT RISK INFORMATION

BOXED WARNING

WARNING: NOT FOR TREATMENT OF OBESITY OR FOR WEIGHT LOSS

  • THYROID HORMONES, ALONE OR IN COMBINATION, SHOULD NOT BE USED FOR WEIGHT LOSS OR OBESITY TREATMENT. 

  • IN EUTHYROID PATIENTS, DOSES WITHIN NORMAL HORMONAL REQUIREMENTS ARE INEFFECTIVE FOR WEIGHT REDUCTION. 

  • LARGER DOSES MAY PRODUCE SERIOUS OR LIFE‑THREATENING TOXICITY, PARTICULARLY WHEN USED WITH SYMPATHOMIMETIC AMINES. 

Warnings and Precautions

Cardiovascular Risk
  • Use with extreme caution in:  

    • Patients with coronary artery disease or angina 

    • Elderly patients 

  • Therapy should be initiated at low doses and titrated carefully, as thyroid hormones may precipitate:

    • Angina

    • Arrhythmias

    • Myocardial infarction

Risk of Over‑Replacement (Hyperthyroidism) 
  • Excess dosing may result in symptoms of hyperthyroidism, including:

    • Palpitations

    • Tachycardia

    • Nervousness 

    • Heat intolerance 

  • Liothyronine (T3) content may produce more rapid and pronounced effects 

Endocrine Effects 
  • May worsen:  

    • Diabetes mellitus (increased insulin/oral hypoglycemic requirements) 

    • Adrenal insufficiency (must be corrected prior to therapy) 

  • Requires careful monitoring and dose adjustment 

Anticoagulant Sensitivity 
  • Thyroid hormones may increase response to oral anticoagulants

  • Monitor prothrombin time/INR and adjust anticoagulant dose as needed 

Special Populations 

  • Pediatric patients: Excess dosing may cause craniosynostosis

  • Pregnancy: Continue therapy; dose adjustments may be required 

  • Lactation: Use with caution 

Adverse Reactions 

  • Adverse reactions are generally due to overdosage and resemble hyperthyroidism: 

    • Palpitations

    • Tachycardia

    • Arrhythmias

    • Nervousness

    • Insomnia

    • Tremor

    • Heat intolerance

  • Other reactions are rare when properly dosed 

Drug Interactions

  • Decreased absorption:

    • Cholestyramine (separate dosing by 4–5 hours) 

  • Increased anticoagulant effects 

  • Altered glycemic control with insulin or oral hypoglycemics 

  • Estrogens/oral contraceptives:  

    • May increase thyroid hormone requirements 

Dosage and Administration  

  • Dosage must be individualized based on clinical response and laboratory monitoring (TSH, T4, T3)

  • Typically initiated at low doses and titrated gradually, especially in patients with cardiovascular disease 

  • Administer orally; consistency in administration is important 

This is the most important safety information you should know about AMERITHROID®. For more information see full Prescribing Information, including BOXED WARNING.

To report SUSPECTED ADVERSE REACTIONS, contact Oliva Therapeutics, LLC at 1-877-200-6088, or FDA at 1-800-FDA-1088 or www.fda.gov/MedWatch.


All patient and physician images are representative only.

Note that DTE products, including amerithroid, have not been reviewed by the FDA for safety or efficacy.

Indications and Usage 

Thyroid Tablets, USP are indicated for:

  • Replacement or supplemental therapy in hypothyroidism of any etiology (except transient hypothyroidism during recovery from subacute thyroiditis) 

  • TSH suppression in the management of certain goiters and in thyroid cancer 

contraindications

  • Uncorrected adrenal cortical insufficiency

  • Untreated thyrotoxicosis

  • Known hypersensitivity to thyroid hormone preparations or excipients 

IMPORTANT RISK INFORMATION

BOXED WARNING

WARNING: NOT FOR TREATMENT OF OBESITY OR FOR WEIGHT LOSS

  • THYROID HORMONES, ALONE OR IN COMBINATION, SHOULD NOT BE USED FOR WEIGHT LOSS OR OBESITY TREATMENT. 

  • IN EUTHYROID PATIENTS, DOSES WITHIN NORMAL HORMONAL REQUIREMENTS ARE INEFFECTIVE FOR WEIGHT REDUCTION. 

  • LARGER DOSES MAY PRODUCE SERIOUS OR LIFE‑THREATENING TOXICITY, PARTICULARLY WHEN USED WITH SYMPATHOMIMETIC AMINES. 

Warnings and Precautions

Cardiovascular Risk
  • Use with extreme caution in:  

    • Patients with coronary artery disease or angina 

    • Elderly patients 

  • Therapy should be initiated at low doses and titrated carefully, as thyroid hormones may precipitate:

    • Angina

    • Arrhythmias

    • Myocardial infarction

Risk of Over‑Replacement (Hyperthyroidism) 
  • Excess dosing may result in symptoms of hyperthyroidism, including:

    • Palpitations

    • Tachycardia

    • Nervousness 

    • Heat intolerance 

  • Liothyronine (T3) content may produce more rapid and pronounced effects 

Endocrine Effects 
  • May worsen:  

    • Diabetes mellitus (increased insulin/oral hypoglycemic requirements) 

    • Adrenal insufficiency (must be corrected prior to therapy) 

  • Requires careful monitoring and dose adjustment 

Anticoagulant Sensitivity 
  • Thyroid hormones may increase response to oral anticoagulants

  • Monitor prothrombin time/INR and adjust anticoagulant dose as needed 

Special Populations 

  • Pediatric patients: Excess dosing may cause craniosynostosis

  • Pregnancy: Continue therapy; dose adjustments may be required 

  • Lactation: Use with caution 

Adverse Reactions 

  • Adverse reactions are generally due to overdosage and resemble hyperthyroidism: 

    • Palpitations

    • Tachycardia

    • Arrhythmias

    • Nervousness

    • Insomnia

    • Tremor

    • Heat intolerance

  • Other reactions are rare when properly dosed 

Drug Interactions

  • Decreased absorption:

    • Cholestyramine (separate dosing by 4–5 hours) 

  • Increased anticoagulant effects 

  • Altered glycemic control with insulin or oral hypoglycemics 

  • Estrogens/oral contraceptives:  

    • May increase thyroid hormone requirements 

Dosage and Administration  

  • Dosage must be individualized based on clinical response and laboratory monitoring (TSH, T4, T3)

  • Typically initiated at low doses and titrated gradually, especially in patients with cardiovascular disease 

  • Administer orally; consistency in administration is important 

This is the most important safety information you should know about AMERITHROID®. For more information see full Prescribing Information, including BOXED WARNING.

To report SUSPECTED ADVERSE REACTIONS, contact Oliva Therapeutics, LLC at 1-877-200-6088, or FDA at 1-800-FDA-1088 or www.fda.gov/MedWatch.


All patient and physician images are representative only.

Note that DTE products, including amerithroid, have not been reviewed by the FDA for safety or efficacy.

Indications and Usage 

Thyroid Tablets, USP are indicated for:

  • Replacement or supplemental therapy in hypothyroidism of any etiology (except transient hypothyroidism during recovery from subacute thyroiditis) 

  • TSH suppression in the management of certain goiters and in thyroid cancer 

contraindications

  • Uncorrected adrenal cortical insufficiency

  • Untreated thyrotoxicosis

  • Known hypersensitivity to thyroid hormone preparations or excipients 

IMPORTANT RISK INFORMATION

BOXED WARNING

WARNING: NOT FOR TREATMENT OF OBESITY OR FOR WEIGHT LOSS

  • THYROID HORMONES, ALONE OR IN COMBINATION, SHOULD NOT BE USED FOR WEIGHT LOSS OR OBESITY TREATMENT. 

  • IN EUTHYROID PATIENTS, DOSES WITHIN NORMAL HORMONAL REQUIREMENTS ARE INEFFECTIVE FOR WEIGHT REDUCTION. 

  • LARGER DOSES MAY PRODUCE SERIOUS OR LIFE‑THREATENING TOXICITY, PARTICULARLY WHEN USED WITH SYMPATHOMIMETIC AMINES. 

Warnings and Precautions

Cardiovascular Risk
  • Use with extreme caution in:  

    • Patients with coronary artery disease or angina 

    • Elderly patients 

  • Therapy should be initiated at low doses and titrated carefully, as thyroid hormones may precipitate:

    • Angina

    • Arrhythmias

    • Myocardial infarction

Risk of Over‑Replacement (Hyperthyroidism) 
  • Excess dosing may result in symptoms of hyperthyroidism, including:

    • Palpitations

    • Tachycardia

    • Nervousness 

    • Heat intolerance 

  • Liothyronine (T3) content may produce more rapid and pronounced effects 

Endocrine Effects 
  • May worsen:  

    • Diabetes mellitus (increased insulin/oral hypoglycemic requirements) 

    • Adrenal insufficiency (must be corrected prior to therapy) 

  • Requires careful monitoring and dose adjustment 

Anticoagulant Sensitivity 
  • Thyroid hormones may increase response to oral anticoagulants

  • Monitor prothrombin time/INR and adjust anticoagulant dose as needed 

Special Populations 

  • Pediatric patients: Excess dosing may cause craniosynostosis

  • Pregnancy: Continue therapy; dose adjustments may be required 

  • Lactation: Use with caution 

Adverse Reactions 

  • Adverse reactions are generally due to overdosage and resemble hyperthyroidism: 

    • Palpitations

    • Tachycardia

    • Arrhythmias

    • Nervousness

    • Insomnia

    • Tremor

    • Heat intolerance

  • Other reactions are rare when properly dosed 

Drug Interactions

  • Decreased absorption:

    • Cholestyramine (separate dosing by 4–5 hours) 

  • Increased anticoagulant effects 

  • Altered glycemic control with insulin or oral hypoglycemics 

  • Estrogens/oral contraceptives:  

    • May increase thyroid hormone requirements 

Dosage and Administration  

  • Dosage must be individualized based on clinical response and laboratory monitoring (TSH, T4, T3)

  • Typically initiated at low doses and titrated gradually, especially in patients with cardiovascular disease 

  • Administer orally; consistency in administration is important 

This is the most important safety information you should know about AMERITHROID®. For more information see full Prescribing Information, including BOXED WARNING.

To report SUSPECTED ADVERSE REACTIONS, contact Oliva Therapeutics, LLC at 1-877-200-6088, or FDA at 1-800-FDA-1088 or www.fda.gov/MedWatch.


All patient and physician images are representative only.

Amerithroid logo

Amerithroid is a registered trademark of Oliva Therapeutics and is manufactured by Jerome Stevens Pharmaceuticals, Inc.

© 2026 Oliva Therapeutics. All rights reserved.  US-AME-26009-10/26
This site is intended for U.S. healthcare professionals only.

Amerithroid logo

Amerithroid is a registered trademark of Oliva Therapeutics and is manufactured by Jerome Stevens Pharmaceuticals, Inc.
© 2026 Oliva Therapeutics. All rights reserved.  US-AME-26009-10/26
This site is intended for U.S. healthcare professionals only.

Amerithroid logo

Amerithroid is a registered trademark of Oliva Therapeutics and is manufactured by Jerome Stevens Pharmaceuticals, Inc.
© 2026 Oliva Therapeutics. All rights reserved.  US-AME-26009-10/26
This site is intended for U.S. healthcare professionals only.

you are leaving amerithroid.com/hcp

You are about to leave this website and be directed to an external site.

you are leaving amerithroid.com/hcp

You are about to leave this website and be directed to an external site.

you are leaving amerithroid.com/hcp

You are about to leave this website and be directed to an external site.

Note that DTE products, including amerithroid, have not been reviewed by the FDA for safety or efficacy.

Indications and Usage 

Thyroid Tablets, USP are indicated for:

  • Replacement or supplemental therapy in hypothyroidism of any etiology (except transient hypothyroidism during recovery from subacute thyroiditis) 

  • TSH suppression in the management of certain goiters and in thyroid cancer 

IMPORTANT RISK INFORMATION (CONT’D)

contraindications

  • Uncorrected adrenal cortical insufficiency

  • Untreated thyrotoxicosis

  • Known hypersensitivity to thyroid hormone preparations or excipients 

IMPORTANT RISK INFORMATION

BOXED WARNING

WARNING: NOT FOR TREATMENT OF OBESITY OR FOR WEIGHT LOSS

  • THYROID HORMONES, ALONE OR IN COMBINATION, SHOULD NOT BE USED FOR WEIGHT LOSS OR OBESITY TREATMENT. 

  • IN EUTHYROID PATIENTS, DOSES WITHIN NORMAL HORMONAL REQUIREMENTS ARE INEFFECTIVE FOR WEIGHT REDUCTION. 

  • LARGER DOSES MAY PRODUCE SERIOUS OR LIFE‑THREATENING TOXICITY, PARTICULARLY WHEN USED WITH SYMPATHOMIMETIC AMINES. 

Warnings and Precautions

Cardiovascular Risk
  • Use with extreme caution in:  

    • Patients with coronary artery disease or angina 

    • Elderly patients 

  • Therapy should be initiated at low doses and titrated carefully, as thyroid hormones may precipitate:

    • Angina

    • Arrhythmias

    • Myocardial infarction

Risk of Over‑Replacement (Hyperthyroidism) 
  • Excess dosing may result in symptoms of hyperthyroidism, including:

    • Palpitations

    • Tachycardia

    • Nervousness 

    • Heat intolerance 

  • Liothyronine (T3) content may produce more rapid and pronounced effects 

Endocrine Effects 
  • May worsen:  

    • Diabetes mellitus (increased insulin/oral hypoglycemic requirements) 

    • Adrenal insufficiency (must be corrected prior to therapy) 

  • Requires careful monitoring and dose adjustment 

Anticoagulant Sensitivity 
  • Thyroid hormones may increase response to oral anticoagulants

  • Monitor prothrombin time/INR and adjust anticoagulant dose as needed 

Special Populations 

  • Pediatric patients: Excess dosing may cause craniosynostosis

  • Pregnancy: Continue therapy; dose adjustments may be required 

  • Lactation: Use with caution 

Adverse Reactions 

  • Adverse reactions are generally due to overdosage and resemble hyperthyroidism: 

    • Palpitations

    • Tachycardia

    • Arrhythmias

    • Nervousness

    • Insomnia

    • Tremor

    • Heat intolerance

  • Other reactions are rare when properly dosed 

Drug Interactions

  • Decreased absorption:

    • Cholestyramine (separate dosing by 4–5 hours) 

  • Increased anticoagulant effects 

  • Altered glycemic control with insulin or oral hypoglycemics 

  • Estrogens/oral contraceptives:  

    • May increase thyroid hormone requirements 

Dosage and Administration  

  • Dosage must be individualized based on clinical response and laboratory monitoring (TSH, T4, T3)

  • Typically initiated at low doses and titrated gradually, especially in patients with cardiovascular disease 

  • Administer orally; consistency in administration is important 

This is the most important safety information you should know about AMERITHROID®. For more information see full Prescribing Information, including BOXED WARNING.

To report SUSPECTED ADVERSE REACTIONS, contact Oliva Therapeutics, LLC at 1-877-200-6088, or FDA at 1-800-FDA-1088 or www.fda.gov/MedWatch.


All patient and physician images are representative only.

Note that DTE products, including amerithroid, have not been reviewed by the FDA for safety or efficacy.

Indications and Usage 

Thyroid Tablets, USP are indicated for:

  • Replacement or supplemental therapy in hypothyroidism of any etiology (except transient hypothyroidism during recovery from subacute thyroiditis) 

  • TSH suppression in the management of certain goiters and in thyroid cancer 

IMPORTANT RISK INFORMATION (CONT’D)

contraindications

  • Uncorrected adrenal cortical insufficiency

  • Untreated thyrotoxicosis

  • Known hypersensitivity to thyroid hormone preparations or excipients 

IMPORTANT RISK INFORMATION

BOXED WARNING

WARNING: NOT FOR TREATMENT OF OBESITY OR FOR WEIGHT LOSS

  • THYROID HORMONES, ALONE OR IN COMBINATION, SHOULD NOT BE USED FOR WEIGHT LOSS OR OBESITY TREATMENT. 

  • IN EUTHYROID PATIENTS, DOSES WITHIN NORMAL HORMONAL REQUIREMENTS ARE INEFFECTIVE FOR WEIGHT REDUCTION. 

  • LARGER DOSES MAY PRODUCE SERIOUS OR LIFE‑THREATENING TOXICITY, PARTICULARLY WHEN USED WITH SYMPATHOMIMETIC AMINES. 

Warnings and Precautions

Cardiovascular Risk
  • Use with extreme caution in:  

    • Patients with coronary artery disease or angina 

    • Elderly patients 

  • Therapy should be initiated at low doses and titrated carefully, as thyroid hormones may precipitate:

    • Angina

    • Arrhythmias

    • Myocardial infarction

Risk of Over‑Replacement (Hyperthyroidism) 
  • Excess dosing may result in symptoms of hyperthyroidism, including:

    • Palpitations

    • Tachycardia

    • Nervousness 

    • Heat intolerance 

  • Liothyronine (T3) content may produce more rapid and pronounced effects 

Endocrine Effects 
  • May worsen:  

    • Diabetes mellitus (increased insulin/oral hypoglycemic requirements) 

    • Adrenal insufficiency (must be corrected prior to therapy) 

  • Requires careful monitoring and dose adjustment 

Anticoagulant Sensitivity 
  • Thyroid hormones may increase response to oral anticoagulants

  • Monitor prothrombin time/INR and adjust anticoagulant dose as needed 

Special Populations 

  • Pediatric patients: Excess dosing may cause craniosynostosis

  • Pregnancy: Continue therapy; dose adjustments may be required 

  • Lactation: Use with caution 

Adverse Reactions 

  • Adverse reactions are generally due to overdosage and resemble hyperthyroidism: 

    • Palpitations

    • Tachycardia

    • Arrhythmias

    • Nervousness

    • Insomnia

    • Tremor

    • Heat intolerance

  • Other reactions are rare when properly dosed 

Drug Interactions

  • Decreased absorption:

    • Cholestyramine (separate dosing by 4–5 hours) 

  • Increased anticoagulant effects 

  • Altered glycemic control with insulin or oral hypoglycemics 

  • Estrogens/oral contraceptives:  

    • May increase thyroid hormone requirements 

Dosage and Administration  

  • Dosage must be individualized based on clinical response and laboratory monitoring (TSH, T4, T3)

  • Typically initiated at low doses and titrated gradually, especially in patients with cardiovascular disease 

  • Administer orally; consistency in administration is important 

This is the most important safety information you should know about AMERITHROID®. For more information see full Prescribing Information, including BOXED WARNING.

To report SUSPECTED ADVERSE REACTIONS, contact Oliva Therapeutics, LLC at 1-877-200-6088, or FDA at 1-800-FDA-1088 or www.fda.gov/MedWatch.


All patient and physician images are representative only.

Note that DTE products, including amerithroid, have not been reviewed by the FDA for safety or efficacy.

Indications and Usage 

Thyroid Tablets, USP are indicated for:

  • Replacement or supplemental therapy in hypothyroidism of any etiology (except transient hypothyroidism during recovery from subacute thyroiditis) 

  • TSH suppression in the management of certain goiters and in thyroid cancer 

IMPORTANT RISK INFORMATION (CONT’D)

contraindications

  • Uncorrected adrenal cortical insufficiency

  • Untreated thyrotoxicosis

  • Known hypersensitivity to thyroid hormone preparations or excipients 

IMPORTANT RISK INFORMATION

BOXED WARNING

WARNING: NOT FOR TREATMENT OF OBESITY OR FOR WEIGHT LOSS

  • THYROID HORMONES, ALONE OR IN COMBINATION, SHOULD NOT BE USED FOR WEIGHT LOSS OR OBESITY TREATMENT. 

  • IN EUTHYROID PATIENTS, DOSES WITHIN NORMAL HORMONAL REQUIREMENTS ARE INEFFECTIVE FOR WEIGHT REDUCTION. 

  • LARGER DOSES MAY PRODUCE SERIOUS OR LIFE‑THREATENING TOXICITY, PARTICULARLY WHEN USED WITH SYMPATHOMIMETIC AMINES. 

Warnings and Precautions

Cardiovascular Risk
  • Use with extreme caution in:  

    • Patients with coronary artery disease or angina 

    • Elderly patients 

  • Therapy should be initiated at low doses and titrated carefully, as thyroid hormones may precipitate:

    • Angina

    • Arrhythmias

    • Myocardial infarction

Risk of Over‑Replacement (Hyperthyroidism) 
  • Excess dosing may result in symptoms of hyperthyroidism, including:

    • Palpitations

    • Tachycardia

    • Nervousness 

    • Heat intolerance 

  • Liothyronine (T3) content may produce more rapid and pronounced effects 

Endocrine Effects 
  • May worsen:  

    • Diabetes mellitus (increased insulin/oral hypoglycemic requirements) 

    • Adrenal insufficiency (must be corrected prior to therapy) 

  • Requires careful monitoring and dose adjustment 

Anticoagulant Sensitivity 
  • Thyroid hormones may increase response to oral anticoagulants

  • Monitor prothrombin time/INR and adjust anticoagulant dose as needed 

Special Populations 

  • Pediatric patients: Excess dosing may cause craniosynostosis

  • Pregnancy: Continue therapy; dose adjustments may be required 

  • Lactation: Use with caution 

Adverse Reactions 

  • Adverse reactions are generally due to overdosage and resemble hyperthyroidism: 

    • Palpitations

    • Tachycardia

    • Arrhythmias

    • Nervousness

    • Insomnia

    • Tremor

    • Heat intolerance

  • Other reactions are rare when properly dosed 

Drug Interactions

  • Decreased absorption:

    • Cholestyramine (separate dosing by 4–5 hours) 

  • Increased anticoagulant effects 

  • Altered glycemic control with insulin or oral hypoglycemics 

  • Estrogens/oral contraceptives:  

    • May increase thyroid hormone requirements 

Dosage and Administration  

  • Dosage must be individualized based on clinical response and laboratory monitoring (TSH, T4, T3)

  • Typically initiated at low doses and titrated gradually, especially in patients with cardiovascular disease 

  • Administer orally; consistency in administration is important 

This is the most important safety information you should know about AMERITHROID®. For more information see full Prescribing Information, including BOXED WARNING.

To report SUSPECTED ADVERSE REACTIONS, contact Oliva Therapeutics, LLC at 1-877-200-6088, or FDA at 1-800-FDA-1088 or www.fda.gov/MedWatch.


All patient and physician images are representative only.